VERTEX PHARMACEUTICALS INC / MA Public Float
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Public Float of $113.40 billion as of 2025-06-30, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-13
- 2025-06-30: Entity Public Float $113.40B.
- 2024-06-28: Entity Public Float $121.80B.
- 2023-06-30: Entity Public Float $90.70B.
- 2022-06-30: Entity Public Float $71.80B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $113.40B 10-K · filed 2026-02-13 |
| 2024-06-28 | $121.80B 10-K · filed 2025-02-13 |
| 2023-06-30 | $90.70B 10-K · filed 2024-02-15 |
| 2022-06-30 | $71.80B 10-K · filed 2023-02-10 |
| 2021-06-30 | $51.60B 10-K · filed 2022-02-09 |
| 2020-06-30 | $74.80B 10-K · filed 2021-02-11 |
| 2019-06-28 | $46.70B 10-K · filed 2020-02-13 |
| 2018-06-29 | $42.50B 10-K · filed 2019-02-13 |
| 2017-06-30 | $31.80B 10-K · filed 2018-02-15 |
| 2016-06-30 | $21.10B 10-K · filed 2017-02-23 |
| 2015-06-30 | $30.00B 10-K · filed 2016-02-16 |
| 2014-06-30 | $22.40B 10-K · filed 2015-02-13 |
| 2013-06-30 | $18.50B 10-K · filed 2014-02-11 |
| 2012-06-29 | $11.90B 10-K · filed 2013-03-01 |
| 2011-06-30 | $10.70B 10-K · filed 2012-02-22 |
| 2010-06-30 | $6.60B 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |